Clinical Trial: Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional




Official Title: Phase II Trial of Ritonavir/Lopinavir in Patients With Progressive of Recurrent High-Grade Gliomas

Brief Summary: RATIONALE: Ritonavir and lopinavir may stop the growth of gliomas by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. PURPOSE: This phase II trial is studying how well giving ritonavir together with lopinavir works in treating patients with progressive or recurrent high-grade glioma.